SFI
MRNA icon

Susquehanna Fundamental Investments’s Moderna MRNA Stock Holding History

Susquehanna Fundamental Investments’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-113,865
Closed -$3.14M – 698
2025
Q2 		$3.14M Sell
113,865
-331,613
-74% -$8.73M 0.08% 261
2025
Q1 		$12.6M Buy
445,478
+59,801
+16% +$2.12M 0.18% 138
2024
Q4 		$16M Buy
+385,677
New +$18.4M 0.23% 105
2024
Q2 		$4.04M Buy
+33,987
New +$4.3M 0.09% 266

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Susquehanna Fundamental Investments's MRNA Position: Q3 2025 in Review

Susquehanna Fundamental Investments sold out of Moderna (MRNA) in Q3 2025, closing a stake of 113,865 shares — an estimated $3.14M sold.

Susquehanna Fundamental Investments first reported a position in MRNA in Q2 2024 and held it in 4 quarters. The position peaked at $16M in Q4 2024. 644 funds tracked by Wall St. Rank hold MRNA as of Q3 2025.

  • Susquehanna Fundamental Investments reported no remaining Moderna position as of Q3 2025 after selling out during the quarter.
  • Susquehanna Fundamental Investments sold 113,865 Moderna shares in Q3 2025, an estimated $3.14M.
  • Susquehanna Fundamental Investments first reported a position in Moderna in Q2 2024 and held it in 4 quarters.
  • Susquehanna Fundamental Investments's Moderna position peaked at $16M in Q4 2024.
  • 644 funds tracked by Wall St. Rank held Moderna as of Q3 2025.

Based on Susquehanna Fundamental Investments's 13F filing for Q3 2025, filed 14 Nov 2025.